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Abstract
Background: “Frosted branch retinal angiitis” is an encompassing term for a rare, typically bilateral diffuse retinal
periphlebitis that may occur in a number of varying conditions. To our knowledge, we report the first case of
frosted branch angiitis as the presenting sign of antiphospholipid antibody syndrome in a 28-year-old woman.
Findings: This study is a retrospective case report and literature review. Serial fundus photos, fluorescein angiogram,
and ocular coherence tomography taken were before and after treatment, showing resolution of diffuse retinal
perivascular sheathing and macular edema along with marked improvement in visual acuity 4 months after the
treatment with corticosteroids.
Conclusions: Frosted branch angiitis can be seen in association with antiphospholipid antibody syndrome.
Prompt recognition and treatment with corticosteroids may result in good visual prognosis, and long-term
immunosuppression and additional anticoagulation may be beneficial to prevent recurrence.
Keywords: Retinal vasculitis, Frosted branch angiitis, Antiphospholipid antibody syndrome, Hydroxychloroquine
Findings
Introduction
“Frosted branch retinal angiitis” is an encompassing term
for a rare, typically bilateral diffuse retinal periphlebitis
that may occur in a number of varying conditions. To
our knowledge, we report the first case of frosted branch
angiitis in a patient with the antiphospholipid antibody
syndrome.
Case report
A 28-year-old Hispanic female with past medical history
significant for migraine headaches and remote spontan-
eous abortion presented to an outside hospital with a
2-month history of fatigue and severe headache. Initial
bloodwork revealed an elevated erythrocyte sedimenta-
tion rate (ESR) at 41 mm/h. Magnetic resonance imaging
(MRI) of the brain, computed tomography angiography
(CTA) of the head and neck, and chest radiograph were
unremarkable. Lumbar puncture disclosed an elevated
cerebrospinal fluid (CSF) white blood cell count (WBC)
with normal CSF protein and glucose. The patient was
admitted to the hospital and empirically started on
intravenous acyclovir for suspected viral meningitis.
Polymerase chain reaction (PCR) testing of the CSF for
herpetic disease as well as CSF culture returned negative.
The diagnosis was modified to aseptic meningitis, and
acyclovir was discontinued after 3 days of therapy. The
consulting neurologist started the patient on a low dose
of oral Solu-Medrol at 4 mg daily, and she was discharged
from the hospital. Over the next 7 days, her headache
persisted. Upon developing visual symptoms including
floaters in both eyes, light sensitivity, and loss of vision in
the right eye, she returned to the hospital. At that point,
an ophthalmologic examination was sought.
On exam, the patient’s best-corrected visual acuity
(BCVA) was count fingers on the right eye and 20/40 on
the left. An afferent pupillary defect was noted on the
right eye. On anterior segment examination, the patient
demonstrated 1+ anterior chamber cell on the right with
no anterior chamber cell on the left. She also had 2+
bilateral vitritis. Funduscopic exam revealed bilateral
diffuse retinal periphlebitis resembling frosted branch
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angiitis (Fig. 1a, b). Fluorescein angiography (FA) showed
slightly delayed retinal-artery-to-vein transit time of 10 s
on the right eye. Late-phase FA demonstrated bilateral
leakage of dye predominantly from the retinal veins and
the optic nerve head (Fig. 1c, d). There was no evidence
of capillary non-perfusion or neovascularization in either
eye on FA. Spectral domain optical coherence tomography
(SD-OCT) of the macula disclosed a large amount of
cystoid macular edema and a serous foveal detachment
on the right and a smaller foveal detachment with trace
intraretinal edema on the left (Fig. 1e, f ).
Subsequent workup for various infectious and in-
flammatory etiologies were significant for an elevated
anti-nuclear antibody (ANA) titer at a 1:320 dilution
with speckled homogenous pattern, an elevated anti-
cardiolipin IgG at 85 GPL (with normal levels of anti-
cardiolipin immunoglobulin m (IgM) and immunoglobu-
lin A (IgA)), and both anti-beta 2 glycoprotein antibody
and lupus anticoagulant being present. Other tests includ-
ing C-reactive protein, human immunodeficiency virus
(HIV) immunoassay, rapid plasma reagin, fluorescent
treponemal antibody absorption, purified protein deriva-
tive (PPD), serum lysozyme, angiotensin-converting en-
zyme, human leukocyte antigen-B51, rheumatoid factor,
anti-neutrophil cytoplasmic antibody, liver function tests,
Sjogren’s syndrome antibody-A (anti-Ro/SSA), anti-La/
SSB, anti-Smith, anti-ribonucleoprotein antibody (Anti-
RNP), anti-centromere antibody, anti-topoisomerase I
antibody (Anti-SCL 70), anti-double-stranded DNA anti-
body, complement C3 and C4, and aqueous humor PCR
for herpes simplex virus, varicella zoster virus, cyto-
megalovirus, and Toxoplasma gondii were negative.
Fig. 1 Fundus photography, fluorescein angiography, and optical coherence tomography of each eye at presentation. a Wide-field fundus photograph
of the right eye (OD) showing diffuse retinal periphlebitis. b Wide-field fundus photograph of the left eye (OS) showing diffuse retinal periphlebitis.
c Late-phase fluorescein angiogram of the right eye (OD) showing leakage of dye predominantly from the retinal veins and the optic nerve head
without deceased transit time or evidence of vascular occlusion. d Late-phase fluorescein angiogram of the left eye (OS) showing leakage of dye
predominantly from the retinal veins and the optic nerve head without deceased transit time or evidence of vascular occlusion. e Spectral domain
ocular coherence tomography (SD-OCT) through the fovea of the right eye (OD) showing a large amount of cystoid macular edema and a serous
foveal detachment. f Spectral domain ocular coherence tomography (SD-OCT) through the fovea of the left eye (OS) showing a smaller foveal
detachment with trace intraretinal edema
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The patient was started on high-dose oral prednisone,
at 1.5 mg/kg/day. One week after the initiation of treat-
ment, the frosted branch angiitis improved. Four months
after initiation of treatment, the patient’s VA was 20/20
in both eyes with resolution of the macular edema in
both eyes (Fig. 2c, d) and markedly diminished perivas-
cular sheathing bilaterally (Fig. 2a, b).
Rheumatology consultation was obtained, and it was
found that the patient did not entirely meet full clinical
diagnostic criteria for systemic lupus erythematosus (SLE).
Subsequent hematology consultation disclosed that the
patient met initial criteria for antiphospholipid antibody
syndrome. Per recommendation by rheumatology, the
patient was started on hydroxychloroquine initially at
400 mg daily as her systemic corticosteroids were
tapered off.
Seven months after the initiation of treatment, the pa-
tient had persistently positive anti-cardiolipin IgG, anti-
beta 2 glycoprotein antibody, and lupus anticoagulant.
At this point, hematology confirmed the diagnosis of
primary antiphospholipid antibody syndrome. Following
a long discussion of the risks and benefits of long-term
anticoagulation with the patient, she was started on
Coumadin at 5 mg daily with regular international nor-
malized ratio (INR) monitoring.
Discussion
Ito et al. [1] first coined the term frosted branch angiitis
in 1976 where they reported the appearance of thick
perivascular sheathing in a 6-year-old boy’s fundus recal-
ling imagery of frosted tree branches during an icy
winter. Frosted branch angiitis may be idiopathic or
associated with various systemic conditions including
SLE [2, 3], Behcet’s disease [4], Crohn’s disease [5], cyto-
megalovirus (CMV) retinitis [6], herpes simplex type 2
infection [7], mycobacterium tuberculosis infection [8],
T. gondii infection [9], various other viral and bacterial
infections [10], aseptic meningitis [11], and blood dys-
crasias such as leukemia [12] and lymphoma [13].
Additional retinal findings may include intraretinal
hemorrhages, hard exudates, and serous exudative de-
tachments of the macula and periphery. A proposed
mechanism of retinopathy involves immune complex
deposition in retinal vessels causing vasculitis [14]. Pa-
tients may complain of sudden onset of blurred vision,
central scotomas, floaters, and photopsias, and most
patients respond to systemic corticosteroid therapy
with good recovery of visual acuity.
Antiphospholipid antibody syndrome (APS) is an ac-
quired thrombophilic disorder in which autoantibodies
are produced against a variety of phospholipids and
phospholipid-binding proteins. Diagnostic criteria for
APS include one clinical event and one laboratory find-
ing. Clinically, a suspected patient must have suffered
either vascular thrombosis (which may be venous,
arterial, or small vessel) without significant evidence of
inflammation in the vessel wall or have suffered preg-
nancy morbidity (fetal death after 10 weeks gestation,
premature birth before 34 weeks associated with
eclampsia, pre-eclampsia, or placental insufficiency, or
three or more spontaneous abortions before the tenth
week of gestation). Regarding the laboratory finding,
the patient must have elevated levels of one of the fol-
lowing autoantibodies in serum or plasma on two or
Fig. 2 Fundus photography and OCT 4 months after treatment with corticosteroids. a Wide-field fundus photograph of the right eye (OD)
showing markedly diminished perivascular sheathing. b Wide-field fundus photograph of the left eye (OS) showing markedly diminished perivascular
sheathing. c Spectral domain ocular coherence tomography (SD-OCT) through the fovea of the right eye (OD) showing resolved macular edema.
d Spectral domain ocular coherence tomography (SD-OCT) through the fovea of the left eye (OS) showing resolved macular edema
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more occasions measured at least 12 weeks apart: lupus
anticoagulant (LAC), anti-cardiolipin of IgG and/or IgM
isotype (aCL), and/or anti-β2 glycoprotein I (aβ2GPI)
antibody assays. These autoantibodies, collectively re-
ferred to as antiphospholipid antibodies (aPL), may arise
from multiple mechanisms, including molecular mimicry
between human B2GPI (a plasma protein that binds to
negatively charged phospholipids and regulates coagu-
lation) and similar molecules on pathogenic bacteria, as
a reaction against certain medications (phenytoin and
hydralazine among many), and other theorized mecha-
nisms [15]. Generally, aPL may activate platelets, endo-
thelial cells, and monocytes, leading to the inhibition of
the fibrinolytic system, activation of the coagulation
cascade, and possibly activation of the complement
system [16]. The end effect of these pathways may lead
to the thrombosis or fetal demise that is seen clinically
in APS. The ophthalmic manifestations of APS are typ-
ically the result of vessel thrombosis as well, with vaso-
occlusive disease involving the choroidal and retinal
vasculatures as the most common locations for ocular
involvement. Other findings such as anterior segment
inflammation, episcleritis, scleritis, keratoconjunctivitis
sicca, cranial nerve palsies, and ischemic infarcts of the
visual pathway have been reported but are relatively
uncommon [17].
In order to be diagnosed with definite SLE, the
American College of Rheumatology has recommended
that at least four of the 11 diagnostic criteria must be
met. These criteria include (1) malar rash; (2) discoid
rash; (3) photosensitivity; (4) oral or nose ulcers that
are usually painless; (5) non-erosive arthritis in two or
more joints; (6) cardiopulmonary involvement such as
pericarditis or pleuritis; (7) neurologic disease includ-
ing seizures or psychosis; (8) renal disease which may
manifest as proteinuria or urine casts; (9) hematologic
disorders including hemolytic anemia, leukopenia,
lymphopenia, or thrombocytopenia; (10) immunologic
disorder showing the presence of antibodies such as
Anti-DNA, Anti-SM, and/or antiphospholipid anti-
bodies (lupus anticoagulant (LAC), anti-cardiolipin of
IgG and/or IgM isotype (aCL), and/or aβ2GPI); and
(11) having a positive anti-nuclear antibody test (ANA)
[18]. Following consultation with rheumatology, our
patient demonstrated three clinical criteria and thus
did not meet the full diagnostic criteria for SLE.
While retinal vasculitis is well observed in SLE, frosted
branch angiitis has been described in only two patients
with SLE [2, 3]. Both patients had previously met full
diagnostic criteria for SLE without APS and presented
with markedly decreased vision associated with promi-
nent frosted branch periphlebitis. One patient received
1 g of IV methylprednisolone per day for 4 days, 2 units
of packed erythrocytes, and 6 months of oral steroids
and achieved marked visual improvement from HM OU
to 20/60 OU. The other was treated with 500 mg of IV
methylprednisolone daily for 3 days, followed by 3 weeks
of 75 mg of prednisone along with 100 mg of azathioprine
(patient’s chronic medication) daily, achieving nearly total
remission of retinal lesions in 3 weeks with return of vi-
sion from 5/400 OU to 20/20 OU.
There exists a relationship between SLE and APS and
clinically, patients may fall along a spectrum of disease.
Patients with APS may have SLE. However, if patients
with APS do not meet the American College of Rheuma-
tology criteria for SLE diagnosis, they are diagnosed as
having primary APS, as was the case in our patient.
Gomez-Puerta et al. [19] found that that after median
disease duration of 8.2 years, only 8 % of patients with
primary APS developed SLE, with Coombs positivity
conferring a statistically significant risk for the subse-
quent development of SLE. Montehermoso et al. [20]
further solidified the relationship between SLE retinal
vasculitis and APS, showing that 77 % of patients with
SLE and retinal involvement had positive aPL titers,
while only 29 % of SLE patients without retinal disease
had positive titers. Stratified further, aPL antibodies are
strongly associated with vaso-occlusive disease in SLE, a
condition known as Hughes’ syndrome, and CNS mani-
festations of SLE [21]. Such patients should be initiated
on lifelong anticoagulation therapy in concordance with
APS management.
While SLE retinal vasculitis appears to be associated
with the presence of aPL, frosted branch angiitis is very
rare in the setting of aPL, and has not been previously
described in APS. Abu El-Asrar et al. [22] reported two
cases of retinal periphlebitis resembling frosted branch
angiitis associated with non-perfused CRVO and positive
aPL, but they did not meet the diagnostic criteria for
APS. Despite systemic corticosteroid therapy, 80 mg/day
of aspirin, and full panretinal photocoagulation, both
patients developed rubeosis iridis and profound visual
loss associated with neovascular glaucoma in one pa-
tient. Our patient, in contrast, had better visual and
anatomical outcomes presumably due to the fact that
we were able to identify and treat the retinopathy
prior to the onset of widespread retinal ischemia and
neovascularization.
The recommended primary treatment for APS is pre-
vention of recurrent thrombosis or fetal morbidity with
anticoagulation, and a discussion between the patient
and physician should revolve around this decision. Once
a patient has a proven thrombosis associated with aPL,
lifelong anticoagulation is advisable. Many alternatives
to Coumadin now exist, and the exact choice of anticoa-
gulation should be tailored to the patient.
Hydroxychloroquine (HCQ) has also been shown to
be protective against thrombosis in aPL-positive patients
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[23], and as in our patient, it may be reasonable to rec-
ommend HCQ for thrombosis prevention in APS as an
add-on or alternative treatment option in cases resistant
to other treatment modalities. While the drug is desir-
able for its steroid-sparing properties, a treatment period
of roughly 6 months is required to reach steady state
levels [24], and thus systemic immunosuppression with
corticosteroids is often used in the acute setting.
In summary, to our knowledge, this is the first case of
frosted branch angiitis seen in association with antipho-
spholipid antibody syndrome. With prompt treatment
with corticosteroids, visual prognosis can be good. In
these cases, long-term immunosuppression and additional
anticoagulation may be beneficial to prevent recurrence.
Appropriate consultations to hematology and rheuma-
tology services are recommended. Ophthalmologists,
rheumatologists, and hematologists should be aware of
this possible association.
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